文献速递胸部介入CT

经胸CT引导空芯针活检非恶性病理结果:良性结果何时真正为良性

Non-malignant pathological results on transthoracic CT guided core-needle biopsy: when is benign really benign?
PubMed 文献 · Clin Radiol · 2018-06-06

研究纳入950例首次经胸CT引导空芯针活检(TTNB)结果为非恶性病变的患者,将初始活检结果与最终诊断比较。非恶性结果的阴性预测值为83.6%;特异性感染或良性肿瘤(n=225,26.1%)均经后续证实为真阴性,仅1例「肉芽肿」诊断假阴性。年龄(p=0.002)、癌症史(p<0.001)、靶病灶大小(p=0.003)及活检时气胸(p=0.003)为假阴性的显著预测因素;47.6%(410/861)的患者接受额外有创检查,其中52.7%(216/410)最终确诊。

要点

  • 非恶性TTNB结果的阴性预测值为83.6%,特异性感染、良性肿瘤及肉芽肿性炎症多为真阴性。
  • 假阴性全部来自「感染未特指(NOS)」「炎症性疾病」或「结论不确定」三组,仅1例「肉芽肿」为假阴性。
  • 年龄、癌症史、靶病灶较大及活检时气胸是假阴性的显著预测因素,此类情况常需额外有创检查确诊。

核心结论

  • 首次TTNB的特异性感染、良性肿瘤及肉芽肿性炎症结果大多为真阴性;年龄较大、癌症史、靶病灶较大及气胸对恶性肿瘤假阴性有高度预测价值,此类情况常需额外有创检查以获得最终诊断。

研究设计与样本

  • 研究为比较初始TTNB结果与后续确立的最终诊断,纳入950例首次经胸CT引导空芯针活检初始结果为非恶性病变的患者;原文未写明中心数、设备型号及参考标准的具体定义。

诊断标准与关键数值

  • 非恶性病变的阴性预测值为83.6%。
  • 活检提示特异性感染或良性肿瘤者(n=225,26.1%)后续均证实为恶性阴性。
  • 假阴性者共141例(141/861,16.4%),全部来自「感染未特指(NOS)」「炎症性疾病」或「结论不确定」组,仅1例「肉芽肿」诊断为假阴性。
  • 年龄(p=0.002)、癌症史(p<0.001)、靶病灶大小(p=0.003)、活检时气胸(p=0.003)为假阴性结果的显著预测因素。

临床应用与阅片要点

  • 解读TTNB非恶性结果时需结合年龄、癌症史、靶病灶大小及是否并发出血或气胸评估假阴性风险。
  • 报告「感染未特指(NOS)」「炎症性疾病」或「结论不确定」时,提示此类结果与恶性肿瘤假阴性相关,原文报告47.6%(410/861)的患者接受额外有创检查,52.7%(216/410)最终确诊。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To determine true negatives and characterise the variables associated with false-negative results when interpreting non-malignant results of computed tomography (CT)-guided lung biopsy.

MATERIALS AND METHODS: Nine hundred and fifty patients with initial non-malignant findings on their first transthoracic CT-guided core-needle biopsy (TTNB) were included in the study. Initial biopsy results were compared to definitive diagnoses established later.

RESULTS: The negative predictive value (NPV) of non-malignant diseases upon initial TTNB was 83.6%. When the biopsy results indicated specific infection or benign tumour (n=225, 26.1%), they all were confirmed true negative for malignancy later. Only one inconclusive "granuloma" diagnosis was false negative. All 141 patients (141/861, 16.4%) who were false negative for malignancy were from the "infection not otherwise specified (NOS)", "inflammatory diseases", or "inconclusive" groups. Age (p=0.002), cancer history (p<0.001), target size (p=0.003), and pneumothorax during lung biopsy (p=0.003) were found to be significant predictors of false-negative results; 47.6% (410/861) of patients underwent additional invasive examinations to reach a final diagnosis. Ultimately, 52.7% (216/410) were successfully diagnosed.

CONCLUSION: Specific infection, benign tumour, and granulomatous inflammation of first TTNBs were mostly true negative. Older age, history of cancer, larger target size, and pneumothorax were highly predictive of false-negative results for malignancies. In such cases, additional invasive examinations were frequently necessary to obtain final diagnoses.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Rui Y, Han M, Zhou W, et al. Non-malignant pathological results on transthoracic CT guided core-needle biopsy: when is benign really benign? Clin Radiol. 2018. PMID: 29884525. doi:10.1016/j.crad.2018.03.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。